Borealis Biosciences was founded on the premise that a convergence of scientific and translational breakthroughs is enabling the field of RNA medicines to treat kidney diseases and beyond. The company is backed by founding investor Versant Ventures and Novartis AG, and has a strategic collaboration with the pharma.
Saved company profile
Historical company information from a saved The Jobs API profile (LinkedIn/Crunchbase fields). It is not live-verified; figures may have changed. Missing values remain unknown.
RNA Medicines for Kidney Disease
Full company description
Borealis Biosciences was founded on the premise that a convergence of scientific and translational breakthroughs is enabling the field of RNA medicines to treat kidney diseases and beyond. The company is backed by founding investor Versant Ventures and Novartis AG, and has a strategic collaboration with the pharma.
LinkedIn followers
7,222
People associated on LinkedIn
54
Business categories
Biotechnology
Life Science
Medical
Other recorded names
Borealis Biosciences, Inc.
Profile identifies a recruitment agency
No
Reported total investment
180,000,000
Currency and observation date were not supplied; this is not a current valuation or a funding round.
Industry
Biotechnology Research
Size
11-50 employees
Organization type
Privately Held
Year founded
2024
Borealis Biosciences, Inc. has 3 open jobs in Canada as of November 7, 2026. Top locations: Vancouver.
Borealis Biosciences, Inc.: The company is backed by founding investor Versant Ventures and Novartis AG, and has a strategic collaboration with the pharma.
10+ YOEBorealis Biosciences needs a PhD in a related science with 10+ years of industry experience, or a BS/MS with equivalent experience. Candidates need hands-on assay development skills, regulated method validation experience, and a proven record of managing outsourced lab work through IND-enabling studies into early clinical development.
Borealis Biosciences, Inc.: The company is backed by founding investor Versant Ventures and Novartis AG, and has a strategic collaboration with the pharma.
Candidates need significant clinical operations leadership in biotech or pharma, proven success running outsourced trials, and experience with early-stage and Phase 1/2 studies. They also need strong knowledge of ICH-GCP and experience building teams and processes.
Borealis Biosciences, Inc.: The company is backed by founding investor Versant Ventures and Novartis AG, and has a strategic collaboration with the pharma.
Future roles would likely call for scientific expertise in molecular biology, chemistry, pharmacology or bioinformatics.